Italy· 035120017
RAPAMUNE*orale soluz 60 ml + 30 siringhe
A sirolimus product containing sirolimus, registered in Italy by PFIZER EUROPE MA EEIG, on the national reimbursement list.
Checked against the register on
Informational only — not a medical device.
The record
At a glance
- Active substance
- Sirolimus
- Manufacturer
- PFIZER EUROPE MA EEIG
- Country
- Italy (IT)
- ATC code
- S01XA23
- ATC class
- Sirolimus
- Reimbursed
- Yes
- Last checked
- June 4, 2026
Packs & prices · 1
1 priced- aic035120017RAPAMUNE*orale soluz 60 ml + 30 siringheEUR 348.52
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Sirolimus in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesFYARROAadi Bioscience, Inc.
- United KingdomHyftor 2mg/g gelPlusultra Pharma UK Ltd
- CzechiaHYFTORPlusultra pharma GmbH, Düsseldorf
- SwitzerlandRapamune 0.5 mg, überzogene TablettenPfizer AG
- IrelandHYFTOR 2 mg/g GelPlusultra Pharma GmbH
- FinlandHyftorPlusultra Pharma GmbH
- NorwayRapamunePfizer Europe MA EEIG (1)
- PolandHyftorPlusultra pharma GmbH
Authorised across Europe · EMA
The same active substance is authorised in 4 EEA countries. Names it is sold under:
- Germany · Sirolimus Panacea Biotec
- Iceland · Hyftor, Rapamune
- Liechtenstein · Hyftor, Rapamune
- Norway · Hyftor, Rapamune
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of the issuing authority. This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/824df784-ef7a-4b00-b8ed-ac0e38ab82f3 GET /v1/drugs/824df784-ef7a-4b00-b8ed-ac0e38ab82f3?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"price": 348.52,
"source": "aifa",
"currency": "EUR",
"strength": "SIROLIMUS 1MG/ML 60ML USO ORALE",
"substance": "Sirolimus",
"equivalence_group": "RVB",
"transparency_flag": null
}See everything about sirolimus.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.